How Boehringer, Lilly Are Taming The GenAI Dragon For Regulatory, Commercial Content

Open AI's GPT-4 A Hit Among Users

 
• By Vibha Ravi
Generative AI ChatGPT
It's Time For Pharma To Get On With Generative AI • Source: Shutterstock

More from Business

More from Scrip